Assay of Fletcher Factor (Plasma Prekallikrein) Using an Artificial Clotting Reagent and a Modified Chromogenic Assay

Summary

An artificial clotting reagent lacking in Fletcher factor (plasma prekallikrein, PPK) was made by mixing human plasma, activated by 5 mg/ml of celite, then kept 16 hours at 37° to destroy most of the plasma kallikrein, plus rabbit plasma (which is devoid of XII and Fletcher activity).

Chromogenic assay using a tripeptide substrate was also modified to exclude the interference of the endogenous contact factors. Celite eluate was used instead of kaolin or dextran sulphate for the activation.

Using both these methods, it is possible to distinguish between Fletcher trait (PPK deficiency) and other contact factors such as factor XII and HMWK deficiencies, which do not activate with kaolin or dextran sulphate. These simple clotting and enzymatic assays give specific and well correlated results for PPK estimation.

• References

• 1 Amundsen E, Svendsen L, Vennerod AM, Laak K. 1974. Determination of plasma kallikrein with a new chromogenic tripeptide derivative. In Pisano JJ, Ansten KF. (Eds) Chemistry and Biology of the kallikrein-kinin system in health and disease. Fogarty Intemat Center Proc Dhew Publ. (NIH); 27 215 76, 791
• 2 Colman EW, Bagdassarian A, Talamo RD, Scott CF, Seavey M, Guinaraes JA, Piera JV, Kaplan A. 1975; Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. Journal of Clinical Investigations 56: 1650
• 3 Donaldson VH, Glueck HI, Miller MA, Movat HZ, Habal F. 1976; Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis. Journal of Laboratory and Clinical Medicine 87: 327
• 4 Gjonnaess H. 1972; Cold-promoted activation of factor VII. Thrombosis et Diathesis Haemor- rhagica 28: 155
• 5 Kluft C. 1978; Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein. Journal of Laboratory and Clinical Medicine 91: 83
• 6 Lacombe MJ, Varet BA, Levy JP. 1975; A hitherto undescribed plasma factor acting at the contact phase of blood coagulation (Flaujeac factor): case report and coagulation studies. Blood 46: 761
• 7 Lacombe MJ, Varet B, Levy JP. 1975; A hitherto undescribed plasma factor acting at the contact phase of blood coagulation (Flaujeac factor): case report and coagulation studies. Blood 46: 761
• 8 Ogston D, Ogston CM, Ratnoff OD, Forbes CD. 1959; Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. Journal of Clinical Investigations 48: 1786
• 9 Saito H, Goldsmith GA, Ratnoff OD. Fletcher factor activity in plasmas of various species. Proceedings of Society of Experimental Biology and Medicine 1974; 147: 519
• 10 Wadmann R, Abraham JP. 1974; Fitzgerald factor: A heterofore unrecognized coagulation factor. Blood 44: 934 (Abst.)
• 11 Wuepper KD. 1973; Prekallikrein deficiency in man. Journal of Experimental Medicine 138: 1435
• 12 Wuepper KD, Miller DR, Lacombe MJ. 1975; Deficiency of human plasma kininogen. Journal of Clinical Investigations 56: 1163